Allergy/Asthma News

Policies designed to reduce air pollutants could result in a lower incidence of childhood asthma, researchers reported in the Proceedings of the National Academy of Sciences.

The FDA has approved a combination therapy digital inhaler for treatment of asthma in patients aged 12 years and older, according to a manufacturer press release.

The 20-year cost of uncontrolled asthma in the U.S. is estimated to exceed $963 billion, and both adolescents and adults could lose approximately 15.46 million quality-adjusted life-years as a result, according to a study published in the American Journal of Respiratory and Critical Care Medicine.

The prevalence of poor asthma control during pregnancy is high among women in the United States, especially among the Medicaid population, and dispensing of long-term controller medication is low, new data suggest.

The FDA approved Dupixent for use with other medicines to treat patients with chronic rhinosinusitis with nasal polyps, the agency, Regeneron Pharmaceuticals and Sanofi all announced today.

Advanced glycation end products, or AGEs, which are found in abundance in junk food, are likely associated with the significant increase of food allergies among children in recent years, according to study results presented at the annual meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition.

Older adults with asthma who received interventions specific to their needs and barriers experienced improvements in asthma outcomes, quality of life and self-management behaviors compared with patients who received standard care, according to study results published in JAMA Internal Medicine.

Numerous studies have implicated Staphylococcus aureus in the development of eczema.

Susan R. Bailey, MD, an allergist and immunologist based in Fort Worth, Texas, was voted in as president-elect of the AMA at the organization’s 2019 meeting.

All children attending school in the United States are permitted to carry albuterol inhalers if they have been prescribed one by a physician. However, few children — approximately 14% — have access to emergency inhalers, according to research published in Pediatric Allergy, Immunology and Pulmonology.